Table 2.
Comparative Results of Hepatocellular Carcinoma between α-IFN Plus Cis-platinum Treated Group (n=30) and Non-antitumor Therapy Group (n=26)
IFN- α plus cis-platinum group | Control group | |
---|---|---|
Complete Response | 0(0.0%) | 0(0.0%) |
Partial Response | 4(13.3%) | 0(0.0%) |
Stable disease | 15(50.0%) | 5(19.2%) |
Progressive disease | 11(36.7%) | 21(80.8%) |
| ||
Total | 30(100%) | 26(100.0%) |